Correction to: Human skin-derived ABCB5+ stem cell injection improves liver disease parameters in Mdr2KO mice

Correction to: Human skin-derived ABCB5⁺ stem cell injection improves liver disease parameters in Mdr2KO mice

Arch Toxicol. 2019 Dec;93(12):3669-3670. doi: 10.1007/s00204-019-02603-6. Epub 2019 Oct 29.

¹ Section Molecular Hepatology, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
² Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt.
³ RHEACELL GmbH and Co. KG, 69120, Heidelberg, Germany.
⁴ TICEBA GmbH, 69120, Heidelberg, Germany.
⁵ Applied Molecular Hepatology, Department of Visceral Transplantation, Thoracic und Vascular Surgery, Leipzig University, 04103, Leipzig, Germany.
⁶ Department of Pediatrics and Dermatology, Harvard Medical School, Boston, MA, 02115, USA.
⁷ Section Molecular Hepatology, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. steven.dooley@medma.uni-heidelberg.de.

We wish to submit a corrigendum to the above-mentioned article. Thank you very much for consideration and publication.